Unit-linked insurance plans (ULIPs) and similar India-domiciled insurance-linked investment products — where premiums are split between a small life-insurance component and a much larger fund-investing component — are widely sold in India, including to NRIs, often through India-based agents who may not be thinking about US tax consequences at all. For a US person (citizen, green card holder, or US tax resident), the label 'insurance' on the product doesn't automatically exempt it from PFIC treatment, and in practice, most Indian ULIPs are caught by the same PFIC regime covered in more depth in our companion piece on Indian mutual funds as a PFIC trap.
Why US tax law looks past the insurance wrapper
US tax law has its own definition of what qualifies as 'life insurance' for tax purposes (under Internal Revenue Code Section 7702), built around specific cash-value-accumulation and premium tests designed to ensure a real, dominant insurance risk component. Many Indian ULIPs fail these tests because the investment portion is large relative to the death benefit — which means the IRS doesn't respect the policy as insurance for US tax purposes at all. Once that happens, the underlying 'units' — which are themselves invested in pools of Indian equities, debt, or mutual-fund-like structures — get treated as a direct holding in one or more Passive Foreign Investment Companies, subjecting the ULIP to the same excess-distribution default tax regime and Form 8621 filing obligations as a directly-held Indian mutual fund.
A possible added layer: US excise tax on premiums
Separately from PFIC treatment, US law imposes an excise tax under Internal Revenue Code Section 4371 on premiums paid to foreign insurers, which in principle could apply to premiums paid into an Indian ULIP or endowment plan. The US-India income tax treaty is understood to provide a path to exemption from this excise tax for insurers, but the mechanics run through a closing agreement between the foreign insurer and the IRS rather than something an individual policyholder files directly — whether a specific Indian insurer has such an agreement in place, and whether it's relevant to your policy, is genuinely uncertain from the policyholder's side and worth raising with a cross-border tax preparer rather than assuming either way.
Why caution matters before buying, not just after
Because ULIPs are frequently pitched in India as tax-efficient insurance-cum-investment products — true enough under Indian tax law — NRIs who are US taxpayers can end up holding one without any of the US-side implications having been flagged by the seller. Given the PFIC default regime's punitive treatment (top marginal rate on gains regardless of your actual bracket, plus retroactive interest charges, as detailed in our mutual-fund-trap article), the more common practical advice from cross-border tax preparers is to avoid buying new ULIPs as a US taxpayer altogether, and to get an existing one reviewed for PFIC exposure and Form 8621 filing history rather than assume it's been handled.